Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2013 May;15(5):646–647. doi: 10.1093/neuonc/nos389

Erratum

PMCID: PMC3635521

Erratum for “CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009” by Dolecek et al. Neuro Oncol 2012 Nov; 14(Suppl 5): 1-49.

During the entering of new data, Figures 7, 8, and 14 encountered a conversion problem changing counts to percentages. The data accuracy was verified when figure analyses were rerun for all 17 slides; however, the following corrections should be noted:

Figure 7. Ages 0-19 Other Astrocytoma/Glioblastoma, the correct percentage should be 12.3%

Figure 7. Ages 20+ Other Astrocytoma/Glioblastoma, the correct percentage should be 2.2%

Figure 8. Histology Oligodendroglioma, the correct percentage should be 4.5%, Hemangioma, the correct percentage should be 2.0%, Craniopharyngioma, the correct percentage should be 1.4%

Figure 14. Ages 15-19 Oligodendroglioma, the correct percentage should be 2.3%.

graphic file with name nos38901.jpg

graphic file with name nos38902.jpg

graphic file with name nos38903.jpg


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES